Latest filing published 18 Oct 2024 for Scilex Holding Co, €914.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -58.5%Entry US$21.14 · Close at T+365 US$8.77
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Dorman Followwill: trading record in brief
Dorman Followwill has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Scilex Holding Co and Sorrento Therapeutics, Inc. Over a trading history stretching from 11 November 2020 to 18 October 2024, the count stands at 4 filings.
On the open market, the record shows 1 purchase worth €914 and 1 sale worth €5,874. Taken together, the sales exceed the purchases by €4,960. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 option exercise. 2024 to date brings 1 purchase and no sales.
The latest filing, published on 18 October 2024, reports an open-market purchase of €914 in Scilex Holding Co. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dorman Followwill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$0.9941.6% of flowCommon StockSEC:0000950170-24-115630:0Canonical exit: 16 Jan 2025 (T+90)
- 1,000 shares@ US$1.3758.4% of flowCommon StockSEC:0000950170-24-078116:0
- 1,000 shares0Common StockSEC:0001209191-21-005470:0
- 1,000 shares@ US$7.14Common StockSEC:0001209191-21-005470:1
4 of 4 declarations